A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus
Clinical trial NCT06530849 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06530849
- Sponsor
- Gracell Biotechnologies (Shanghai) Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-22
- Primary completion
- 2027-02-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.